2256770-44-0
Chemical Structure
Bafrekalant
- CAS No.: 2256770-44-0
- Formula:C29H31ClN6O2
- Molecular Weight:531.05
IUPAC Name: (3-chloro-6-methoxypyridin-2-yl)(3-((2-(4-isopropylphenyl)imidazo[1,2-a]pyrimidin-3-yl)methyl)-3,8-diazabicyclo[3.2.1]octan-8-yl)methanone
InChIKey: VDKJCAWGDJJKNL-UHFFFAOYSA-N
SMILES: CC(C1=CC=C(C=C1)C2=C(N(C=CC=N3)C3=N2)CN(CC4CC5)CC5N4C(C(N=C6OC)=C(C=C6)Cl)=O)C
Biological Activity: Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1).
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bafrekalant | 99.80% | Bafrekalant is a diazabicyclic substituted imidazo[l,2-a]pyrimidine-derivative. Bafrekalant has the potential for the research of breathing disorders, including sleep-related breathing disorders such as obstructive and central sleep apnea and snoring (extracted from patent WO2018228907A1). | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
Keywords
